China Pharma Holdings (CPHI) EBITDA (2010 - 2026)
China Pharma Holdings (CPHI) posted EBITDA of -$329,990 for Q2 2026, compared with -$331,257 a year earlier.
Powered by 
Analysis
China Pharma Holdings (CPHI) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at China Pharma Holdings was -$1.44 million; for FY2025, it was -$1.74 million.
- In prior years, China Pharma Holdings' EBITDA was -$1.97 million in FY2024, $1,833 in FY2023, -$848,444 in FY2022 and $227,310 in FY2021 (+124.7%).
- Quarterly EBITDA has run from a low of -$747,963 in Q4 2024 to a high of $282,403 in Q1 2023 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$136,694 (Q1 2026), -$702,770 (Q4 2025) and -$272,111 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | China Pharma Holdings | 22.89 Mn | 21.77 Mn | 83,566.00 | -329,990.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -329,990.00 |
| Mar 31, 2026 | -136,694.00 |
| Dec 31, 2025 | -702,770.00 |
| Sep 30, 2025 | -272,111.00 |
| Jun 30, 2025 | -331,257.00 |
| Mar 31, 2025 | -429,305.00 |
| Dec 31, 2024 | -747,963.00 |
| Sep 30, 2024 | -388,314.00 |
| Jun 30, 2024 | -652,269.00 |
| Mar 31, 2024 | -182,254.00 |
| Dec 31, 2023 | -488,656.00 |
| Sep 30, 2023 | -30,448.00 |
| Jun 30, 2023 | 238,534.00 |
| Mar 31, 2023 | 282,403.00 |
| Dec 31, 2022 | -529,587.00 |
| Sep 30, 2022 | -24,317.00 |
| Jun 30, 2022 | -96,379.00 |
| Mar 31, 2022 | -198,161.00 |
| Dec 31, 2021 | 62,026.00 |
| Sep 30, 2021 | 214,053.00 |
API Access
China Pharma Holdings EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();